Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet
Crypto|2025-07-29 at 17:42 UTC|Source: cointelegraph.com
The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.